BLT1-mediated O-GlcNAcylation is required for NOX2-dependent migration, exocytotic degranulation and IL-8 release of human mast cell induced by Trichomonas vaginalis-secreted LTB4

Microbes Infect. 2018 Jun-Jul;20(6):376-384. doi: 10.1016/j.micinf.2018.05.005. Epub 2018 May 31.

Abstract

Trichomonas vaginalis is a sexually-transmitted protozoan parasite that causes vaginitis and cervicitis. Although mast cell activation is important for provoking tissue inflammation during infection with parasites, information regarding the signaling mechanisms in mast cell activation and T. vaginalis infection is limited. O-linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification of serine and threonine residues that functions as a critical regulator of intracellular signaling, regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). We investigated if O-GlcNAcylation was associated with mast cell activation induced by T. vaginalis-derived secretory products (TvSP). Modified TvSP collected from live trichomonads treated with the 5-lipooxygenase inhibitor AA861 inhibited migration of mast cells. This result suggested that mast cell migration was caused by stimulation of T. vaginalis-secreted leukotrienes. Using the BLT1 antagonist U75302 or BLT1 siRNA, we found that migration of mast cells was evoked via LTB4 receptor (BLT1). Furthermore, TvSP induced protein O-GlcNAcylation and OGT expression in HMC-1 cells, which was prevented by transfection with BLT1 siRNA. TvSP-induced migration, ROS generation, CD63 expression and IL-8 release were significantly suppressed by pretreatment with OGT inhibitor ST045849 or OGT siRNA. These results suggested that BLT1-mediated OGlcNAcylation was important for mast cell activation during trichomoniasis.

Keywords: BLT1; Human mast cells; Leukotriene B(4); NOX2; O-GlcNAcylation; Trichomonas vaginalis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylglucosamine / metabolism*
  • Acylation
  • Cell Line
  • Cell Movement / drug effects
  • Culture Media, Conditioned / pharmacology
  • Exocytosis / drug effects
  • Host-Parasite Interactions
  • Humans
  • Interleukin-8 / metabolism
  • Leukotriene B4 / metabolism*
  • Leukotriene B4 / pharmacology
  • Lipoxygenase Inhibitors / pharmacology
  • Mast Cells / drug effects
  • Mast Cells / metabolism*
  • Mast Cells / parasitology
  • N-Acetylglucosaminyltransferases / antagonists & inhibitors
  • N-Acetylglucosaminyltransferases / metabolism
  • NADPH Oxidase 2 / antagonists & inhibitors
  • NADPH Oxidase 2 / metabolism*
  • RNA, Small Interfering / metabolism
  • Reactive Oxygen Species / metabolism
  • Receptors, Leukotriene B4 / antagonists & inhibitors
  • Receptors, Leukotriene B4 / metabolism*
  • Signal Transduction
  • Trichomonas Infections / metabolism
  • Trichomonas Infections / parasitology
  • Trichomonas vaginalis / drug effects
  • Trichomonas vaginalis / metabolism*

Substances

  • CXCL8 protein, human
  • Culture Media, Conditioned
  • Interleukin-8
  • LTB4R protein, human
  • Lipoxygenase Inhibitors
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Receptors, Leukotriene B4
  • Leukotriene B4
  • NADPH Oxidase 2
  • N-Acetylglucosaminyltransferases
  • O-GlcNAc transferase
  • Acetylglucosamine